David Rowe

6.2k total citations · 1 hit paper
88 papers, 4.9k citations indexed

About

David Rowe is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Rowe has authored 88 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 39 papers in Epidemiology and 29 papers in Infectious Diseases. Recurrent topics in David Rowe's work include Viral-associated cancers and disorders (62 papers), Cytomegalovirus and herpesvirus research (35 papers) and Parvovirus B19 Infection Studies (26 papers). David Rowe is often cited by papers focused on Viral-associated cancers and disorders (62 papers), Cytomegalovirus and herpesvirus research (35 papers) and Parvovirus B19 Infection Studies (26 papers). David Rowe collaborates with scholars based in United States, United Kingdom and Canada. David Rowe's co-authors include Paul J. Farrell, L. Qu, Cliona M. Rooney, Martin Rowe, Alan B. Rickinson, Michael Green, Jorgé Reyes, Lawrence S. Young, Christopher D. Gregory and Philip E. Branton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The EMBO Journal.

In The Last Decade

David Rowe

88 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

1987 588 citations David Rowe, Paul J. Farrell et al. profile →

Peers

Countries citing papers authored by David Rowe

Since Specialization

Citations

This map shows the geographic impact of David Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rowe more than expected).

Fields of papers citing papers by David Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rowe. The network helps show where David Rowe may publish in the future.

Co-authorship network of co-authors of David Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of David Rowe. A scholar is included among the top collaborators of David Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rowe. David Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intravascular abscess in Lemierre's syndrome due to meticillin-sensitive Staphylococcus aureus 2018 ·The Lancet Infectious Diseases ·Bing Mei Teh, Rachel A. Gordon, David Rowe, Andrew Fuller, (unknown)	3
2	EBV-Specific CD8+ T Cells from Asymptomatic Pediatric Thoracic Transplant Patients Carrying Chronic High EBV Loads Display Contrasting Features: Activated Phenotype and Exhausted Function 2011 ·The Journal of Immunology ·Camila Macedo, Steven A. Webber, Albert D. Donnenberg, Iulia Popescu, Yun Hua, Michael Green, David Rowe, Louise Smith, Maria M. Brooks, Diana Metes	35
3	Cellular factors associated with latency and spontaneous Epstein–Barr virus reactivation in B-lymphoblastoid cell lines 2010 ·Virology ·Michael L. Davies, (unknown), James Lyons‐Weiler, Adam Rosendorff, Steven A. Webber, (unknown), Diana Metes, David Rowe	34
4	Detection of HHV‐8 (human herpesvirus‐8) genomes in induced peripheral blood mononuclear cells (PBMCs) from US blood donors 2010 ·Vox Sanguinis ·L. Qu, Darrell J. Triulzi, David Rowe, Frank J. Jenkins	8
5	Treatment-dependent Loss of Polyfunctional CD8+ T-cell Responses in HIV-infected Kidney Transplant Recipients Is Associated with Herpesvirus Reactivation 2009 ·American Journal of Transplantation ·Olivier Gasser, Florian Bihl, Sonali Sanghavi, Charles R. Rinaldo, David Rowe, Christoph Hess, D Stablein, Michelle E. Roland, Peter G. Stock, Christian Brander	32
6	The Impact of EBV Load on T-Cell Immunity in Pediatric Thoracic Transplant Recipients 2009 ·Transplantation ·Camila Macedo, Adriana Zeevi, Carol Bentlejewski, Iulia Popescu, Michael Green, David Rowe, Louise Smith, Steve Webber, Diana Metes	16
7	Effects of storage and leukoreduction on lymphocytes and Epstein‐Barr virus genomes in platelet concentrates 2009 ·Transfusion ·Lirong Qu, David Rowe, Albert D. Donnenberg, Deborah Griffin, Darrell J. Triulzi	8
8	Chronic high Epstein‐Barr viral load carriage in pediatric liver transplant recipients 2008 ·Pediatric Transplantation ·Michael Green, Kyle Soltys, David Rowe, Steven A. Webber, (unknown)	58
9	Chronic High Epstein-Barr Viral Load State and Risk for Late-Onset Posttransplant Lymphoproliferative Disease/Lymphoma in Children 2008 ·American Journal of Transplantation ·Michael Bingler, Brian Feingold, Susan A. Miller, Eric S. Quivers, Marian G. Michaels, (unknown), Robert M. Wadowsky, David Rowe, Steven A. Webber	103
10	DC-SIGN on B Lymphocytes Is Required For Transmission of HIV-1 to T Lymphocytes 2006 ·PLoS Pathogens ·Giovanna Rappocciolo, Paolo Piazza, Craig L. Fuller, Todd A. Reinhart, Simon C. Watkins, David Rowe, Mariel Jais, Phalguni Gupta, Charles R. Rinaldo	89
11	Efficacy of Epstein‐Barr virus removal by leukoreduction of red blood cells 2005 ·Transfusion ·Lirong Qu, (unknown), David Rowe, Darrell J. Triulzi	21
12	Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome 2002 ·Transplantation ·Ronald Holmes, (unknown), F Karrer, David Rowe, Michael R. Narkewicz, Ronald J. Sokol	42
13	EX VIVO GENERATION OF EFFECTIVE EPSTEIN-BARR VIRUS (EBV)-SPECIFIC CD8+ CYTOTOXIC T LYMPHOCYTES FROM THE PERIPHERAL BLOOD OF IMMUNOCOMPETENT EPSTEIN BARR VIRUS-SERONEGATIVE INDIVIDUALS1 2000 ·Transplantation ·Diana Metes, Walter J. Storkus, Adriana Zeevi, (unknown), (unknown), David Rowe, (unknown), John J. Fung, Abdul S. Rao	24
14	PREDICTIVE NEGATIVE VALUE OF PERSISTENT LOW EPSTEIN-BARR VIRUS VIRAL LOAD AFTER INTESTINAL TRANSPLANTATION IN CHILDREN12 2000 ·Transplantation ·Michael Green, Javier Bueno, David Rowe, George Mazariegos, Lirong Qu, (unknown), Jorge Reyes	83
15	The management of Epstein–Barr virus associated post‐transplant lymphoproliferative disorders in pediatric solid‐organ transplant recipients 1999 ·Pediatric Transplantation ·Michael Green, Marian G. Michaels, Steven A. Webber, David Rowe, Jorgé Reyes	87
16	SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1 1998 ·Transplantation ·Michael D. Green, Thomas V. Cacciarelli, George Mazariegos, Lúther Sigurðsson, (unknown), David Rowe, Jorge Reyes	131
17	Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. 1996 ·DIAL (Catholic University of Leuven) ·M Green, Jorgé Reyes, Nicolas Jabbour, Eduardo J. Yunis, (unknown), S Todo, David Rowe	23
18	Protein–Protein Interactions between Epstein–Barr Virus Nuclear Antigen-LP and Cellular Gene Products: Binding of 70-Kilodalton Heat Shock Proteins 1996 ·Virology ·(unknown), David Rowe	40
19	Cell growth effects of Epstein--Barr virus leader protein 1992 ·Journal of General Virology ·Grant Allan, Gareth J. Inman, (unknown), David Rowe, Paul J. Farrell	35
20	The Type-specific Epitopes of the Epstein-Barr Virus Nuclear Antigen 2 Are Near the Carboxy Terminus of the Protein 1989 ·Journal of General Virology ·David Rowe, John R. Clarke	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact